QTMeds

ONDANSETRON ACCORD 2 mg/ml

Clinical Description (Database Summary)

Exact mechanism still unknown. It has been hypothesized that 5HT3 receptor antagonists block cardiac Na channels (Nav1.5), widening the QT interval in a concentration and state-dependent manner

Scientific Sources / References

https://doi.org/10.1186/s43044-023-00385-y, https://www.fda.gov/media/178811/download